The U.S. Food and Drug Administration has announced retail and mail order pharmacies can now sell the abortion pill mifepristone directly to patients with a prescription. The American College of Obstetricians and Gynecologists hailed the move. In a statement, the group said, “Although the FDA’s announcement today will not solve access issues for every person seeking abortion care, it will allow more patients who need mifepristone for medication abortion additional options to secure this vital drug.”